Stay updated on Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Sign up to get notified when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.

Latest updates to the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.6.2 appears in the record history, replacing the older v3.6.0 entry. This indicates a minor update to the page history rather than changes to the trial content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe record history now includes a 'Last verified' timestamp and a 'Last known status was' label, with the current revision shown as v3.6.0. The prior 'Verified' label and sponsor organization details appear to have been removed, reflecting a metadata-display update.SummaryDifference3%

- Check23 days agoChange DetectedThe record history now shows the latest release version is v3.5.5, replacing the previous v3.5.4. This reflects a software update to the site rather than a change to the study details.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.5.4 is now shown in the Study Record Versions, replacing v3.5.3. This indicates a newer revision of the record in the history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe records history shows a new revision tag (v3.5.3) added, replacing the previous v3.5.2. This reflects an updated metadata version for the page without altering displayed content.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.5.2 was added to the Study Record Versions, and Revision: v3.5.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.